Interferon No Better Than Hydroxyurea and Associated With Worse Side Effects in Polycythemia Vera and Essential Thrombocythemia

The use of interferon as initial therapy in MPN is associated with worsening side effects the longer it is used for treatment. This conclusion was based on data recently presented at the 2016 annual meeting of the American Society of Hematology.

 Cancer Connect

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.